GABAPENTIN
NDC 31722-069, GABAPENTIN, solution, from Camber Pharmaceuticals, Inc..
- Product NDC
- 31722-069
- Status
- Listed
- Labeler
- Camber Pharmaceuticals, Inc.
- Dosage form
- SOLUTION
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA217682
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/31722-069 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- GABAPENTIN250 mg/5mL
Pharmacologic classes
Decreased Central Nervous System Disorganized Electrical Activity [PE]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 31722-069-47 | 31722006947 | 1 BOTTLE in 1 CARTON (31722-069-47) / 470 mL in 1 BOTTLE |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/b86c81d9-9a4a-4847-be18-520e5cc5dc4bNADAC price for package 31722006947
GET /v1/drugs/nadac/31722006947
Use it
Look up 31722-069 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/31722-069 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 31722-069. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.